Table 1 Histoclinical correlations of breast cancers according to CD146 expression

Age

   < 45 years

36/74

NS

9/85

NS

   ≥ 45 years

59/115

36/549

Pathological type

   Ductal

92/179

NS

36/472

NS

   Lobular

17/43

2/77

   Tubular

1/40

   Medullar

1/8

   Mixed

2/25

   Other

4/26

Molecular subtype

   Basal

44/67

<0.0001

   ERBB2

15/31

   Luminal

32/93

   Normal

16/21

Scarff Bloom and Richardson grade

   I + II

26/77

<0.0001

18/463

<0.0001

   III

87/149

27/163

Tumor size

   < 20

28/53

NS

17/281

NS

   ≥ 20

54/122

26/347

Pathological axillary lymph node status

   Negative

52/90

NS

   Positive

54/122

Immunohistochemistry estrogen receptor status

   Negative

72/119

<0.0001

28/141

<0.0001

   Positive

41/108

13/460

Immunohistochemistry progesterone receptor status

   Negative

83/137

<0.0001

35/208

<0.0001

   Positive

30/90

9/362

Immunohistochemistry ERBB2 status

   Negative

83/169

NS

40/515

NS

   Positive

19/36

2/46

Immunohistochemistry estrogen receptor/progesterone receptor/ERBB2 status

   Triple negative

25/76

<0.0001

   Other

13/425

Immunohistochemistry p53 status

   Negative

14/330

0.0046

   Positive

15/124

Immunohistochemistry Bcl2 status

   Negative

22/138

<0.0001

   Positive

18/388

Immunohistochemistry CD44 status

   Negative

1/136

0.0225

   Positive

17/283

Immunohistochemistry epithelial growth factor receptor status

   Negative

3/284

0.00011

   Positive

9/81

Immunohistochemistry GATA3 status

   Negative

30/203

0.00032

   Positive

10/313

Immunohistochemistry Moesin status

   Negative

4/339

<0.0001

   Positive

13/65

Immunohistochemistry P-cadherin status

   Negative

1/199

0.00021

   Positive

14/173